Dihydropyridine calcium antagonists: the role in current therapy of cardio-vascular diseases

被引：0
|
作者：
Shilova, E. V. [1 ]
Martsevich, S. Y. [1 ]
机构：
[1] State Res Ctr prevent Med Rosmedtechnol, Moscow, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2008年 / 4卷 / 02期
关键词：
calcium antagonists; dihydropiridines; arterial hypertension; ischemic heart disease; cardiovascular risk; amlodipine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Classification of calcium antagonists (CA) is presented. Results of the large clinical trials (STONE, STOP-Hypertension-2, ALLHAT, ASCOT-BPLA etc.) devoted to estimation of CA effects on the risk of cardiovascular complications are analyzed. The significant place of dihydropyridine CA in current guidelines on arterial hypertension and ischemic heart disease therapy is underlined. Results of a pilot study on comparison of two amlodipines (original Norvasc and generic Stamlo M) are discussed.
引用
收藏
页码：53 / 57
页数：5
相关论文
共 50 条
  • [41] Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
    Carrizzo, Albino
    Forte, Maurizio
    Lembo, Maria
    Formisano, Luigi
    Puca, Annibale A.
    Vecchione, Carmine
    CURRENT DRUG TARGETS, 2014, 15 (13) : 1231 - 1246
  • [42] Geographical peculiarities of the mortality risk of the population of Sumy region from cardio-vascular diseases
    Kornus, Olesia H.
    Kornus, Anatolii O.
    Shyshchuk, Volodymyr D.
    Korol, Olena M.
    JOURNAL OF GEOLOGY GEOGRAPHY AND GEOECOLOGY, 2020, 29 (04): : 710 - 721
  • [43] The Role of a Nurse-Led Clinic in the Assessment and Prevention of Cardio-Vascular Risk
    Martinez-Alberola, Nieves
    Sivera, Francisca
    Fernandez-Carballido, Cristina
    Andres, Mariano
    Martin-Domenech, Raquel
    Martinez-Vidal, Maria Paz
    SanMartin-Alvarez, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [44] ACE2 as a Key Target for Treatment of COVID-19 Related Cardio-vascular Diseases: Current Progress and Prospect
    Li, Shuainan
    Ma, Wenya
    Yang, Fan
    Xu, Yan
    Xu, Binbin
    Cai, Benzhi
    CURRENT DRUG TARGETS, 2021, 22 (16) : 1832 - 1843
  • [45] Vascular protective effects of dihydropyridine calcium antagonists -: Involvement of endothelial nitric oxide
    Berkels, R
    Taubert, D
    Rosenkranz, A
    Rösen, R
    PHARMACOLOGY, 2003, 69 (04) : 171 - 176
  • [46] Experience with and perspectives of prevention of cardio-vascular diseases and their risk factors in a framework of the CINDI program in Russia
    Potemkina, RA
    Vartapetova, NV
    Kamadina, TV
    Solovyeva, IM
    KARDIOLOGIYA, 1996, 36 (03) : 35 - 39
  • [47] INFLUENCE OF SOME METEOROLOGICAL FACTORS ON MORTALITY FROM CARDIO-VASCULAR DISEASES IN THE CITY AND IN THE REGION OF PLOVDIV
    Karaslavova, E.
    Dimitrova, T.
    Donchev, N.
    Teneva, B.
    JOURNAL OF ENVIRONMENTAL PROTECTION AND ECOLOGY, 2013, 14 (01): : 323 - 334
  • [48] School of health for patients with cardio-vascular diseases: balance between andragogic and pedagogic educational models
    Kukushkin, S. K.
    Poddubskaya, E. A.
    Lukina, Y. V.
    Bubnova, M. G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (02) : 98 - 102
  • [49] Dual mode of action of dihydropyridine calcium antagonists - A role for nitric oxide
    Dhein, S
    Salameh, A
    Berkels, R
    Klaus, W
    DRUGS, 1999, 58 (03) : 397 - 404
  • [50] PET-CT IN CARDIO-VASCULAR DISEASES: EXPANDING THE FIELD OF NON-INVASIVE IMAGING
    Le Guludec, D.
    Rouzet, F.
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 : S22 - S23
12345